We describe the case of a 67-year-old man with lung cancer, who developed pulmonary tuberculosis (TB) following chemotherapy and subsequently exhibited a paradoxical reaction on positron emission tomography/computed tomography (PET/CT) after initiating antituberculosis therapy. While pulmonary consolidations improved with antituberculosis treatment, newly detected hypermetabolic mediastinal lymph nodes appeared on PET/CT. Based on the clinical course, we provisionally concluded that the mediastinal lymphadenopathy represented a paradoxical reaction. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) confirmed the diagnosis of TB. Clinicians added steroids and continued the antituberculosis medication, and follow-up PET/CT showed complete resolution of these lesions. This case highlights the importance of recognizing paradoxical reactions to antituberculosis therapy, when restaging PET/CT reveals divergent findings, with some tumor foci responding and other lesions appearing to be progressing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11854061 | PMC |
| http://dx.doi.org/10.3390/diagnostics15040472 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases.
Eur J Immunol
March 2025
Institut Pasteur, Université de Paris Cité, Unit of Antibodies in Therapy and Pathology, Paris, France.
Allergen-specific antibodies, particularly of the IgE class, are a hallmark of many allergic diseases. Yet paradoxically, (1) a proportion of healthy individuals possess allergen-specific IgE without clinical signs of allergy; (2) some, but not all, allergic individuals develop a more severe disease over time or fail to respond to allergen-specific immunotherapy; and (3) allergen-specific IgG antibodies can inhibit IgE-mediated responses but they can also induce allergic reactions. In this review, we discuss the occurrence of and transition between nonpathogenic and pathogenic allergen-specific antibody responses in the light of a two-stage model.
View Article and Find Full Text PDFClinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study.
Infection
March 2025
Department I of Internal Medicine, Division of Infectious Diseases, Medical Faculty and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Purpose: Tuberculosis (TB) remains a leading cause of morbidity and mortality, with 1.3 million deaths in 2022. Extrapulmonary tuberculosis (EPTB) accounts for approximately 20% of all TB cases.
View Article and Find Full Text PDFParadoxical reaction under dupilumab triggered by occasional ketoprofen intake.
Dermatol Reports
February 2025
Dermatology Unit & Scientific Directorate, Galliera Hospital, Genoa.
Dupilumab, a monoclonal antibody targeting the IL-4/13 signaling pathway, effectively treats moderate-to-severe atopic dermatitis (AD). Common side effects include injection site reactions, conjunctivitis, and respiratory infections. We report the case of a 28-year-old woman with severe AD involving the periocular and chin regions, genital areas, arms, and legs (Eczema Area and Severity Index [EASI]: 24, itch Visual Analog Scale [VAS]: 8) who showed significant improvement after initiating dupilumab therapy.
View Article and Find Full Text PDFSevere Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa Patient.
Dermatol Ther (Heidelb)
February 2025
Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.
This article explores the ongoing research into the complex pathogenesis of hidradenitis suppurativa (HS) and the persistent challenges in finding effective treatments. With 113 clinical studies currently listed on ClinicalTrials.gov, the quest for novel therapeutic approaches for HS remains vigorous.
View Article and Find Full Text PDFLight-Mediated Growth of Gold Nanoplates Carried Out in Total Darkness.
ACS Nano
March 2025
College of Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States.
The plasmon-mediated growth of noble metal nanoplates through the reduction of metal precursors onto resonantly excited seeds lined with planar defects stands out as one of the triumphs of photochemistry and nanometal synthesis. Such growth modes are, however, not without their drawbacks and, with a lack of suitable alternatives, limitations remain on the use of light as a synthetic control. Herein, a two-reagent seed-mediated gold nanoplate synthesis is demonstrated as a photochemical pathway where the illumination of the growth solution, as opposed to the emerging nanoplates, is the key requirement for growth.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!